Capsugel Previews Sprinkle Capsule at CPhI Worldwide - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Capsugel Previews Sprinkle Capsule at CPhI Worldwide



Capsugel is launching a capsule design to improve adherence to treatment regimens for patients who have swallowing difficulties. These patients include babies, children, and older adults as well as patients with medical conditions such as Alzheimer’s, Parkinson's, and multiple sclerosis. The Coni-Snap sprinkle capsule is expected to be available in 2014.

Capsugel tested the new design with caregivers to gauge usability, ease of opening, and user accuracy when sprinkling medications. More than 80 percent of participants described the new design as "easy" or "very easy" to open, according to a qualitative survey performed by Capsugel in May 2013 in the EU and the US.

The Coni-Snap sprinkle capsule will be previewed at Capsugel's booth at CPhI Worldwide 2013 in Frankfurt, Germany (Booth #41G20) and the upcoming 2013 AAPS Annual Meeting and Exposition (Booth #2012) in San Antonio, Texas.

Source: Capsugel

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here